What Silk Road Medical Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| McKhann Chas | Chief Executive Officer | Sep 17 | Disposition to Issuer · D | −1,299,042 | — | — | 0 |
| McKhann Chas | Chief Executive Officer | Sep 17 | Grant / award · A | +1,299,042 | — | — | 1,299,042 |
| McKhann Chas | Chief Executive Officer | Sep 17 | Disposition to Issuer · D | −722,396 | — | — | 0 |
| Jones Marie L. | VP, Finance and CAO | Sep 17 | Disposition to Issuer · D | −79,266 | — | — | 0 |
| Ballinger Kevin J. | Director | Sep 17 | Disposition to Issuer · D | −23,666 | — | — | 0 |
| Zurbay Donald | Director | Sep 17 | Disposition to Issuer · D | −12,610 | — | — | 0 |
| Weatherman Elizabeth H | Director | Sep 17 | Disposition to Issuer · D | −155,004 | — | — | 0 |
| Buchanan Lucas W. | COO & CFO | Sep 17 | Disposition to Issuer · D | −13,518 | — | — | 0 |
| Buchanan Lucas W. | COO & CFO | Sep 17 | Disposition to Issuer · D | −50,876 | — | — | 0 |
| Buchanan Lucas W. | COO & CFO | Sep 17 | Disposition to Issuer · D | −503,295 | — | — | 0 |
| Davis Andrew S. | Chief Commercial Officer | Sep 17 | Disposition to Issuer · D | −42,218 | — | — | 0 |
| Davis Andrew S. | Chief Commercial Officer | Sep 17 | Grant / award · A | +42,218 | — | — | 42,218 |
| Davis Andrew S. | Chief Commercial Officer | Sep 17 | Disposition to Issuer · D | −290,077 | — | — | 0 |
| Klemz Kevin M | EVP/Chief Legal Officer/Sec. | Sep 17 | Disposition to Issuer · D | −29,062 | — | — | 0 |
| Klemz Kevin M | EVP/Chief Legal Officer/Sec. | Sep 17 | Grant / award · A | +29,062 | — | — | 29,062 |
| Klemz Kevin M | EVP/Chief Legal Officer/Sec. | Sep 17 | Disposition to Issuer · D | −162,926 | — | — | 0 |
| Lasersohn Jack W | Director | Sep 17 | Disposition to Issuer · D | −16,735 | — | — | 0 |
| Ruedy Richard | EVPClin&Reg.Affairs&QA | Sep 17 | Disposition to Issuer · D | −70 | — | — | 0 |
| Ruedy Richard | EVPClin&Reg.Affairs&QA | Sep 17 | Disposition to Issuer · D | −26,250 | — | — | 0 |
| Ruedy Richard | EVPClin&Reg.Affairs&QA | Sep 17 | Grant / award · A | +26,250 | — | — | 26,250 |
Loading...